X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (75) 75
Book / eBook (9) 9
Conference Proceeding (5) 5
Publication (4) 4
Book Chapter (2) 2
Newspaper Article (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (21) 21
humans (19) 19
gastroenterology & hepatology (18) 18
male (18) 18
female (17) 17
adult (15) 15
inflammatory bowel disease (11) 11
middle aged (11) 11
pharmacology & pharmacy (10) 10
therapy (10) 10
crohn's disease (9) 9
infliximab (9) 9
life sciences (9) 9
prospective studies (9) 9
analysis (8) 8
meteorology & atmospheric sciences (8) 8
crohns-disease (7) 7
abridged index medicus (6) 6
care and treatment (6) 6
crohn disease - drug therapy (6) 6
gastroenterology and hepatology (6) 6
inflammatory-bowel-disease (6) 6
medical research (6) 6
patients (6) 6
sciences of the universe (6) 6
treatment outcome (6) 6
ulcerative colitis (6) 6
aged (5) 5
climatology (5) 5
cohort studies (5) 5
earth sciences (5) 5
history (5) 5
humidity (5) 5
inflammatory bowel diseases (5) 5
intestine (5) 5
medicine, experimental (5) 5
troposphere (5) 5
water vapor (5) 5
art exhibitions (4) 4
bequests (4) 4
colon (4) 4
efficacy (4) 4
human health and pathology (4) 4
maintenance therapy (4) 4
management (4) 4
manometry (4) 4
model (4) 4
ocean, atmosphere (4) 4
paper (4) 4
pharmacology (4) 4
relative-humidity (4) 4
risk factors (4) 4
silver (4) 4
ulcerative-colitis (4) 4
adolescent (3) 3
ankylosing-spondylitis (3) 3
antibodies, monoclonal - administration & dosage (3) 3
art museums (3) 3
azathioprine (3) 3
bronzes (3) 3
calibration (3) 3
cancer (3) 3
child (3) 3
climate (3) 3
convection (3) 3
crohns disease (3) 3
curators (3) 3
drug therapy, combination (3) 3
environmental sciences (3) 3
gastrointestinal agents - adverse effects (3) 3
gelatins (3) 3
global changes (3) 3
hépatology and gastroenterology (3) 3
index (3) 3
induction therapy (3) 3
inflammation (3) 3
inflammatory bowel diseases - drug therapy (3) 3
inks (3) 3
internal medicine (3) 3
large-scale advection (3) 3
medicine & public health (3) 3
meteorology (3) 3
monoclonal antibodies (3) 3
museum exhibits (3) 3
pharmaceutical sciences (3) 3
pharmacology/toxicology (3) 3
population pharmacokinetics (3) 3
recurrence (3) 3
remission (3) 3
remote sensing (3) 3
retrospective studies (3) 3
studies (3) 3
tropical regions (3) 3
water-vapor channel (3) 3
young adult (3) 3
[ sdu.ocean ] sciences of the universe [physics]/ocean, atmosphere (2) 2
aged, 80 and over (2) 2
algorithms (2) 2
anti-inflammatory agents - administration & dosage (2) 2
anti-inflammatory agents - adverse effects (2) 2
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (6) 6
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Royal Ontario Museum - Stacks (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
UTL at Downsview - May be requested (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Architecture Landscape (Shore + Moffat) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Architectural Design, ISSN 0003-8504, 09/2016, Volume 86, Issue 5, pp. 92 - 99
Patents are the strongest form of intellectual property rights available internationally, so far unbeaten by open source as a body of innovation and know‐how.... 
Shigeru Ban | University of Greenwich | Royal Institute of British Architects (RIBA) | Florence | Charles Babbage | Modular Adaptable Housing Units | Department of Architecture and Landscape | Oliver Patent | Knoll | Richard Buckminster Fuller | Eduardo Torroja | open source architecture | Frank Gehry and Gehry Technologies | Santiago Calatrava | intellectual property rights (IPRs) | Mark Garcia | Joseph Strauss | Frederick Kiesler | Adam Jaffe | Chuck Hoberman | Zaha Hadid Architects | Venice | Filippo Brunelleschi | Arup | Peter Bohlin | micro‐royalties | London | European Patent Office (EPO) | Charles Ellis | Bohlin Cywinski Jackson | Steve Jobs | Thomas Hobbes's | FrontisPatents | global patent system | Mike Aling | Patentscope (the World Intellectual Property Organization (WIPO) database) | Charlotte Perriand | Kieran Timberlake | Auguste Perret | Frank Lloyd Wright | Unites States Patent and Trademark Office (USPTO) | Rem Koolhaas/OMA | Foster + Partners | Le Corbusier | Greenwich Megagram 2.0 | Wallace Harrison | Il Bardalone | SOM | Barack Obama | Airbus | Installation sanitaire | Laurence York | Apple | Kickstarter | Leviathan | Sponsume | Thomas Hobbes's Leviathan | micro-royalties | Trademarks | Patents | Design engineering | Freeware | Landscape architecture | Tracking | Architecture (computers) | Source code | Information technology
Journal Article
Gastroenterology, ISSN 0016-5085, 2012, Volume 142, Issue 1, pp. 63 - 70.e5
Journal Article
Gut, ISSN 0017-5749, 01/2017, Volume 67, Issue 1, pp. 53 - 53
Objective The efficacy of anti-tumour necrosis factors (anti-TNFs) in patients with Crohn's disease (CD) and symptomatic small bowel stricture (SSBS) is... 
FIBROSIS | ENTEROGRAPHY | ENTEROCLYSIS | TRIALS | THERAPY | INFLAMMATION | CONSENSUS | INDEX | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | LESIONS | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Intestinal Obstruction - diagnostic imaging | Adalimumab - adverse effects | Crohn Disease - complications | Adult | Female | Severity of Illness Index | Intestinal Obstruction - etiology | Crohn Disease - diagnostic imaging | Drug Administration Schedule | Treatment Outcome | Magnetic Resonance Imaging | Adalimumab - therapeutic use | Intestinal Obstruction - drug therapy | Adalimumab - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Crohn Disease - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Intestine, Small - diagnostic imaging | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Treatment outcome | Care and treatment | Dosage and administration | Crohn's disease | Adalimumab | Analysis | Corticoids | Nuclear magnetic resonance--NMR | Medical imaging | Clinical trials | Stenosis | Systematic review | Inflammation | Patients | Success | Abdomen | Crohns disease | Inflammatory bowel disease | Pain | Intestine | Surgery | Gangrene | Monoclonal antibodies | Tumor necrosis factor-TNF | Endoscopy | Cancer | Tumors | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Hépatology and Gastroenterology | Immunology | Immunotherapy | ABDOMINAL MRI | CROHN'S DISEASE | Inflammatory Bowel Disease | 1506 | IBD CLINICAL
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2016, Volume 14, Issue 11, pp. 1593 - 1601.e2
Journal Article
Journal Article
by Amiot, A and Serrero, M and Peyrin‐Biroulet, L and Filippi, J and Pariente, B and Roblin, X and Buisson, A and Stefanescu, C and Trang‐Poisson, C and Altwegg, R and Marteau, P and Vaysse, T and Bourrier, A and Nancey, S and Laharie, D and Allez, M and Savoye, G and Moreau, J and Vuitton, L and Viennot, S and Aubourg, A and Pelletier, A.‐L and Bouguen, G and Abitbol, V and Gagniere, C and Bouhnik, Y and Amiot, Aurelien and Gagniere, Charlotte and Serrero, Melanie and Grimaud, Jean‐Charles and Peyrin‐Biroulet, Laurent and Zallot, Camille and Bigard, Marc‐Andre and Filippi, Jerome and Hebuterne, Xavier and Pariente, Benjamin and Nachury, Maria and Desreumaux, Pierre and Roblin, Xavier and Tedesco, Emilie and Buisson, Anthony and Bommelaer, Gilles and Stefanescu, Carmen and Bouhnik, Yoram and Boureille, Arnaud and Trang‐Poisson, Caroline and Altwegg, Romain and Marteau, Philippe and Dray, Xavier and Carbonnel, Franck and Vaysse, Thibaud and Seksik, Philippe and Beaugerie, Laurent and Cosnes, Jacques and Sokol, Harry and Landman, Cecilia and Bourrier, Anne and Nancey, Stephane and Boschetti, Gilles and Laharie, David and Poullenot, Florian and Allez, Matthieu and Gornet, Jean‐Marc and Baudry, Clautilde and Savoye, Guillaume and Moreau, Jacques and Vuitton, Lucine and Koch, Stephane and Viennot, Stephanie and Aubourg, Alexandre and Picon, Laurence and Pelletier, Anne‐Laure and Sickersen, Gaelle and Bouguen, Guillaume and Abitbol, Vered and Chaussade, Stanislas and Nahon, Stephane and Winkfield, Betsy and Brixi‐benmansour, Hedia and Gincul, Rodica and Barberis, Jean‐Christophe and Bonaz, Bruno and Michiels, Christophe and Zerbib, Franck and Beauregard, Marie Bourrier and Locher, Christophe and Davin‐Couve, Sophie and Poirette, Armelle and Guillem, Laurence and Stetiu‐Mocanu, Monica and Philippe, Beau and Beorchia, Sylvain and Al Qaddi, Jawad and GETAID and OBSERV-IBD Study Grp and OBSERV-IBD study group and the GETAID and the OBSERV-IBD study group and the GETAID
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 08/2017, Volume 46, Issue 3, pp. 310 - 321
Journal Article
by Tadbiri, S and Peyrin‐Biroulet, L and Serrero, M and Filippi, J and Pariente, B and Roblin, X and Buisson, A and Stefanescu, C and Trang‐Poisson, C and Altwegg, R and Marteau, P and Vaysse, T and Bourrier, A and Nancey, S and Laharie, D and Allez, M and Savoye, G and Gilletta, C and Gagniere, C and Vuitton, L and Viennot, S and Aubourg, A and Pelletier, A.‐L and Bouguen, G and Abitbol, V and Fumery, M and Claudepierre, P and Bouhnik, Y and Amiot, A and Amiot, Aurelien and Gagniere, Charlotte and Serrero, Melanie and Grimaud, Jean‐Charles and Peyrin‐Biroulet, Laurent and Zallot, Camille and Bigard, Marc‐Andre and Filippi, Jerome and Hebuterne, Xavier and Pariente, Benjamin and Nachury, Maria and Desreumaux, Pierre and Roblin, Xavier and Del Tedesco, Emilie and Buisson, Anthony and Bommelaer, Gilles and Stefanescu, Carmen and Bouhnik, Yoram and Boureille, Arnaud and Trang‐Poisson, Caroline and Altwegg, Romain and Marteau, Philippe and Dray, Xavier and Carbonnel, Franck and Vaysse, Thibaud and Seksik, Philippe and Beaugerie, Laurent and Cosnes, Jacques and Sokol, Harry and Landman, Cecilia and Bourrier, Anne and Nancey, Stephane and Boschetti, Gilles and Laharie, David and Poullenot, Florian and Allez, Matthieu and Gornet, Jean‐Marc and Baudry, Clautilde and Savoye, Guillaume and Moreau, Jacques and Vuitton, Lucine and Koch, Stephane and Viennot, Stephanie and Aubourg, Alexandre and Picon, Laurence and Pelletier, Anne‐Laure and Sickersen, Gaelle and Bouguen, Guillaume and Abitbol, Vered and Chaussade, Stanislas and Fumery, Mathurin and Nahon, Stephane and Winkfield, Betsy and Brixi‐benmansour, Hedia and Gincul, Rodica and Barberis, Jean‐Christophe and Bonaz, Bruno and Michiels, Christophe and Zerbib, Franck and Bourrier de Beauregard, Marie and Locher, Christophe and Davin‐Couve, Sophie and Poirette, Armelle and Guillem, Laurence and Stetiu‐Mocanu, Monica and Philippe, Beau and Beorchia, Sylvain and Al Qaddi, Jawad and GETAID OBSERV-IBD Study Grp and GETAID OBSERV-IBD study group and the GETAID OBSERV-IBD study group
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 02/2018, Volume 47, Issue 4, pp. 485 - 493
Journal Article
Atmospheric Measurement Techniques, ISSN 1867-1381, 06/2017, Volume 10, Issue 6, pp. 2163 - 2181
Journal Article